0 false false false false false false false false false true false false false false false false No description of principal activity 2021-01-01 Sage Accounts Production Advanced 2020 - FRS102_2019 835 167 134 301 534 668 xbrli:pure xbrli:shares iso4217:GBP 11743579 2021-01-01 2021-12-31 11743579 2021-12-31 11743579 2020-12-31 11743579 2020-12-31 11743579 bus:Director1 2021-01-01 2021-12-31 11743579 core:WithinOneYear 2021-12-31 11743579 core:WithinOneYear 2020-12-31 11743579 core:ShareCapital 2021-12-31 11743579 core:ShareCapital 2020-12-31 11743579 core:RetainedEarningsAccumulatedLosses 2021-12-31 11743579 core:RetainedEarningsAccumulatedLosses 2020-12-31 11743579 bus:SmallEntities 2021-01-01 2021-12-31 11743579 bus:AuditExempt-NoAccountantsReport 2021-01-01 2021-12-31 11743579 bus:FullAccounts 2021-01-01 2021-12-31 11743579 bus:SmallCompaniesRegimeForAccounts 2021-01-01 2021-12-31 11743579 bus:PrivateLimitedCompanyLtd 2021-01-01 2021-12-31 11743579 core:ComputerEquipment 2021-01-01 2021-12-31 11743579 core:ComputerEquipment 2021-12-31 11743579 core:ComputerEquipment 2020-12-31
COMPANY REGISTRATION NUMBER: 11743579
M&R QP PHARMA CONSULTANCY LIMITED
Filleted Unaudited Financial Statements
31 December 2021
M&R QP PHARMA CONSULTANCY LIMITED
Statement of Financial Position
31 December 2021
2021
2020
Note
£
£
Fixed assets
Tangible assets
4
534
668
Current assets
Cash at bank and in hand
38,867
35,665
Creditors: amounts falling due within one year
5
10,072
7,354
--------
--------
Net current assets
28,795
28,311
--------
--------
Total assets less current liabilities
29,329
28,979
--------
--------
Capital and reserves
Called up share capital
100
100
Profit and loss account
29,229
28,879
--------
--------
Shareholders funds
29,329
28,979
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 12 September 2022 , and are signed on behalf of the board by:
Dr M Ravindran
Director
Company registration number: 11743579
M&R QP PHARMA CONSULTANCY LIMITED
Notes to the Financial Statements
Year ended 31 December 2021
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 49 Stapleton Road, Formby, Liverpool, L37 2YT.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
20% reducing balance
4. Tangible assets
Equipment
£
Cost
At 1 January 2021 and 31 December 2021
835
----
Depreciation
At 1 January 2021
167
Charge for the year
134
----
At 31 December 2021
301
----
Carrying amount
At 31 December 2021
534
----
At 31 December 2020
668
----
5. Creditors: amounts falling due within one year
2021
2020
£
£
Corporation tax
503
Other creditors
9,569
7,354
--------
-------
10,072
7,354
--------
-------